LON:BXPBEXIMCO PHARMAC/S GDR REGS Share Price, Forecast & News

GBX 45

+2.50 (+5.88 %)

(As of 06/1/2020 05:48 AM ET)

Add

Compare

Today's Range

42.68

Now: GBX 45▼

45.70

50-Day Range

34.50

MA: GBX 38.78▼

52-Week Range

30.88

Now: GBX 45▼

Volume138,803 shs

Average Volume35,555 shs

Market Capitalization£182.50 million

P/E RatioN/A

Dividend Yield3.23%

BetaN/A

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and active pharmaceutical ingredients in Bangladesh. The company offers allergic disorder, analgesic and antipyretic, anti-infective, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, muscloskeletal, oncology, respiratory, skin care, vitamin and mineral supplement, oral contraceptive, anti-histamine, anti-fibrinolytic, women's health, and other products. It also provides contract manufacturing services. In addition, the company exports its products to approximately 40 countries worldwide. Beximco Pharmaceuticals Limited was founded in 1976 and is headquartered in Dhaka, Bangladesh.

Beat the Market (BTM) Rank^™

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for BEXIMCO PHARMAC/S GDR REGS.

2.4 Community Rank

Outperform Votes
BEXIMCO PHARMAC/S GDR REGS has received 108 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
BEXIMCO PHARMAC/S GDR REGS has received 118 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
BEXIMCO PHARMAC/S GDR REGS has received 52.21% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about BEXIMCO PHARMAC/S GDR REGS and other stocks. Vote “Outperform” if you believe BXP will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BXP will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.7 Dividend Strength

Dividend Leadership
BEXIMCO PHARMAC/S GDR REGS is a leading dividend payer. It pays a dividend yield of 3.23%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
BEXIMCO PHARMAC/S GDR REGS does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, BEXIMCO PHARMAC/S GDR REGS insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Overall Beat the Market Rank^™

0.81 out of 5 stars

Industry, Sector and Symbol

Stock Exchange LON

Industry Drug Manufacturers - Major

Sub-IndustryN/A

SectorMedical

Current SymbolLON:BXP

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.beximco-pharma.com

Phone+880-2-58611001

Debt

Debt-to-Equity Ratio35.10

Current Ratio1.02

Quick Ratio0.38

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Employees4,200

Outstanding Shares405,556,000

Market Cap£182.50 million

Next Earnings DateN/A

OptionableOptionable

Receive BXP News and Ratings via Email

Sign-up to receive the latest news and ratings for BXP and its competitors with MarketBeat's FREE daily newsletter.

BEXIMCO PHARMAC/S GDR REGS (LON:BXP) Frequently Asked Questions

How has BEXIMCO PHARMAC/S GDR REGS's stock been impacted by COVID-19 (Coronavirus)?

BEXIMCO PHARMAC/S GDR REGS's stock was trading at GBX 39 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BXP shares have increased by 15.4% and is now trading at GBX 45. View which stocks have been most impacted by Coronavirus.

Has BEXIMCO PHARMAC/S GDR REGS been receiving favorable news coverage?

News stories about BXP stock have trended negative recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. BEXIMCO PHARMAC/S GDR REGS earned a coverage optimism score of -2.6 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutBEXIMCO PHARMAC/S GDR REGS.

Who are some of BEXIMCO PHARMAC/S GDR REGS's key competitors?

Some companies that are related to BEXIMCO PHARMAC/S GDR REGS include Vectura Group (VEC), Medical Developments International (MVP), Eco Animal Health Group (EAH), Allergy Therapeutics (AGY), Trilogy International Partners (TRL), Recce Pharmaceuticals (RCE), Futura Medical (FUM), NanoViricides (NNVC), Vita Life Sciences (VLS), Pharmaxis (PXS), Avivagen (VIV), Antisense Therapeutics (ANP), Sareum (SAR), China Pharma (CPHI) and Patrys (PAB). View all competitors.

Who are BEXIMCO PHARMAC/S GDR REGS's key executives?

BEXIMCO PHARMAC/S GDR REGS's management team includes the following people:

Mr. Nazmul Hassan MP, MD & Director
Mr. Ali Nawaz, Chief Fin. Officer
Mr. Rabbur Reza, Chief Operating Officer
Mr. Jamal Ahmed Choudhury, Exec. Director of Accounts & Fin.
Mr. M. A. Arshad Bhuiyan, Deputy Gen. Mang. of HR

What is BEXIMCO PHARMAC/S GDR REGS's stock symbol?

BEXIMCO PHARMAC/S GDR REGS trades on the London Stock Exchange (LON) under the ticker symbol "BXP."

How do I buy shares of BEXIMCO PHARMAC/S GDR REGS?

Shares of BXP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is BEXIMCO PHARMAC/S GDR REGS's stock price today?

One share of BXP stock can currently be purchased for approximately GBX 45.

How big of a company is BEXIMCO PHARMAC/S GDR REGS?

BEXIMCO PHARMAC/S GDR REGS has a market capitalization of £182.50 million. BEXIMCO PHARMAC/S GDR REGS employs 4,200 workers across the globe.

What is BEXIMCO PHARMAC/S GDR REGS's official website?

The official website for BEXIMCO PHARMAC/S GDR REGS is www.beximco-pharma.com.

How can I contact BEXIMCO PHARMAC/S GDR REGS?

BEXIMCO PHARMAC/S GDR REGS's mailing address is 19 Dhanmondi R/A, Road No. 7, DHAKA, 1205, Bangladesh. The company can be reached via phone at +880-2-58611001.

This page was last updated on 6/1/2020 by MarketBeat.com Staff